A Brave New World: Oregon’s Legal Psilocybin Landscape

image title

Authors: Dave Kopilak and Kaci Hohmann

This article first appeared in the Oregon State Bar Business Law Section Newsletter • March 2023

On Election Day 2020, Oregonians approved Ballot Measure 109, also known as the Oregon Psilocybin Services Act (the Act). It created the nation’s first legal, regulatory framework for the manufacture, sale, and consumption of psilocybin products and the provision of psilocybin services. The Oregon Health Authority (OHA) is the regulating agency.

General framework

Under the Act, clients may purchase, consume, and experience the effects of psilocybin products only at a licensed service center and only under the supervision of a licensed facilitator.

The Act provides for three types of sessions between the client and a licensed facilitator: a preparation session, an administration session, and an integration session. The preparation session is an intake meeting that must occur before the client can participate in an administration session. In the administration session, the client consumes and experiences the effects of a psilocybin product. In the integration session, which is optional on the client’s part, the client and facilitator can discuss the client’s psilocybin experience and how the client may derive lasting meaning from the experience. Group administration sessions are permitted, as are outdoor administration sessions.

The Act provides for four license types: manufacturer, service center operator, facilitator, and laboratory. A manufacturing license includes cultivation, harvesting, production, and processing. A facilitator license applies to an individual, whereas the other licenses could be held by legal entities.

One of the most striking aspects of the Act is its non-medical nature. Although a medical or mental health condition may be the reason a client seeks a psilocybin experience, the Act does not require a client to be diagnosed with or have any particular medical condition to participate. Any client who is eligible can participate for any reason, or for no particular reason at all.

Similarly, the Act expressly provides that the OHA cannot require a facilitator to have a degree from an institution of higher learning. A facilitator must have a high-school diploma or equivalent and must complete a 160-hour education and training program. No further education nor additional professional licenses are required. In fact, the OHA promulgated a rule that prohibits facilitators who hold other professional licenses from practicing their other professions while providing psilocybin services.

The current status

The Act provided for a two-year development period to give the OHA sufficient time to educate itself about psilocybin, to provide information about psilocybin to the public, and to adopt rules. The two-year development period expired on December 31, 2022. After many meetings, many public comments, and much work, the OHA adopted its final set of rules on December 27, 2022, and began to accept applications for licenses on January 2, 2023.

As of March 3, 2023, the OHA had received 13 manufacturer applications, six service center applications, zero facilitator applications, and two laboratory applications, but had not yet issued any licenses. There are currently 20 approved facilitator training programs, but the facilitators in those programs have not yet completed their courses. Individuals likely will begin to apply for facilitator licenses over the next few months.

Colorado and other states

On Election Day 2022, Colorado voters approved Colorado Proposition 122, which provides for a similar (yet more expansive) regulatory framework for psilocybin products and services. Colorado will not begin accepting license applications under Proposition 122 until September 30, 2024, and thus Oregon will be the first state in the country to issue psilocybin licenses to businesses and individuals.

A number of other states are considering various forms of legalization, and it is likely that more states will join Oregon and Colorado over the next few years.

Federal illegality

Like marijuana, psilocybin is classified as a Schedule I controlled substance under the federal Controlled Substances Act. Consequently, just as is the case with marijuana businesses licensed by the Oregon Liquor and Cannabis Commission, any psilocybin business that manufactures, distributes, dispenses, or possesses psilocybin will be in violation of federal law.

Over the years, the United States Department of Justice (US DOJ) made a number of public pronouncements about its enforcement policies concerning marijuana. Probably the most influential of those was an August 29, 2013, document that came to be known as the “Cole Memo” after its author James Cole, who was the Deputy Attorney General at the US DOJ. The Cole Memo was released in response to Colorado and Washington adopting the first adult-use marijuana laws in 2012, and essentially indicated that the US DOJ would take a hands-off approach when it came to state laws that legalized marijuana, so long as such laws provided for strong and effective regulatory and enforcement systems.

The Cole Memo was rescinded on January 4, 2018, by then-United States Attorney General Jeff Sessions, who declared that it was unnecessary, as the US DOJ already had well-established enforcement principles that govern all federal prosecutions. A final public pronouncement was made by the United States Attorney for the District of Oregon (OR DOJ), in a memorandum released on May 18, 2018. That document, which came to be known as the “Williams Memo” after its author, Billy Williams, looked awfully similar to the Cole Memo. For all intents and purposes, the Williams Memo restated the US DOJ’s enforcement policies in the State of Oregon concerning marijuana that were initially laid out in the Cole Memo. The Williams Memo has never been updated or repealed, and presumably remains in effect.

So far, neither the US DOJ nor the OR DOJ has made any public statements about the Act, Colorado’s Proposition 122, or state-regulated psilocybin programs in general. Although one might logically apply (or extend) the Williams Memo to psilocybin within the State of Oregon, there is no guarantee that the US DOJ or the OR DOJ will take any particular course of action. It appears they are taking a “wait and see” approach at the moment. However, anything is possible.

Legal issues for psilocybin businesses

Oregon attorneys who represent psilocybin businesses under the Act will encounter many of the same legal issues that attorneys encounter when representing marijuana businesses. However, with respect to nearly all of those issues, there will be nuanced differences, most of which will make things even more challenging for psilocybin businesses and their attorneys.

Aside from the everyday legal issues that all businesses and attorneys encounter, the following is a list of some of the most important legal issues for psilocybin businesses.

Federal illegality with no federal guidance

The lack of federal guidance may warrant special care when it comes to securities law disclosures, entity organization documents, leases, and other contracts.

The lack of any federal guidance will likely ensure that banks or financial institutions will not openly and knowingly provide banking services to psilocybin businesses, at least for a while.

Section 280E of the Internal Revenue Code

Section 280E prohibits any business trafficking in a Schedule I or Schedule II controlled substance under the federal Controlled Substances Act from deducting any business expenses. In lieu of taking deductions, trafficking businesses can adjust their gross income downward by their cost of goods sold (COGS) to arrive at their taxable income. COGS are the direct costs incurred by a business to acquire or manufacture merchandise. State-regulated marijuana business have been dealing with Section 280E from the outset, and it has always been troublesome. However, Section 280E may have more extreme effects on service center operators (and potentially facilitators) because the “services” component of the Act is so significant. Services are not merchandise. Consequently, none of the service-related expenses incurred by a service center can be categorized as COGS.

Land use

The Act allowed cities and counties to submit ordinances that prohibit manufacturing or service centers in their jurisdiction to their voters for approval in statewide general elections. In November 2022, voters in some jurisdictions did in fact prohibit manufacturing and service centers. However, most of the densely populated areas in Oregon allow all psilocybin businesses. A map of the jurisdictions that have permitted or prohibited psilocybin businesses is provided in a Local Jurisdiction Tracker. Those jurisdictions are now promulgating time, place, and manner restrictions, or grappling with how psilocybin businesses—especially service centers—fit within their existing land-use ordinances. Before leasing or purchasing real property, it is fundamental for a psilocybin business to understand those local ordinances.

OHA rules

The OHA’s final rules implementing the Act are detailed and voluminous. The sheer amount of paperwork involved in providing services to a client is rather astounding. Regulatory compliance will be essential.

Client agreements

In the ordinary course of business, cannabis retailers do not enter into agreements with their customers. However, service-center operators and facilitators almost certainly will be entering into detailed agreements with their clients. They will want to have robust warranty disclaimers, releases, and liability waivers in their client agreements—especially if professional liability insurance for psilocybin services is prohibitively expensive.

Residency requirements

The Act requires that one or more Oregon residents must have more than 50% of the ownership interests of any legal entity that will hold a manufacturer or service center license. Additionally, all facilitators must be Oregon residents. The residency requirements expire on January 1, 2025.


As a result of federal illegality, the United States Patent and Trademark Office will not issue federal trademarks for any psilocybin products. An argument could be made that a facilitator who provides psilocybin services (and nothing more) is not federally illegal, because the facilitator is not manufacturing, distributing, dispensing, possessing, or even touching any psilocybin.

Consequently, federal trademark viability needs to be considered on a case-by-case basis. There are often numerous creative solutions to protect intellectual property even in the absence of federal trademarks.


Following the legalization of marijuana in Oregon, Oregon Rules of Professional Conduct (ORPC) Rule 1.2(d) was adopted to make it expressly clear that Oregon lawyers are permitted to counsel and assist clients regarding Oregon’s marijuana-related laws. In 2022, the Oregon State Bar (OSB) Cannabis and Psychedelics Law Section submitted a formal request to the OSB Legal Ethics Committee to amend ORPC Rule 1.2(d) to permit Oregon lawyers to counsel and assist clients regarding any state and local laws that may be illegal under federal or tribal law. As of the date of this article, the proposed amendment has not been approved.

The road ahead

Oregon’s psilocybin program is in its infancy and as such, there are still many unknowns. Currently, the number of psilocybin licensee applications is small, resulting in a much slower rollout than what we saw in the early days of Oregon’s marijuana industry. As Oregon’s psilocybin ecosystem matures, we hope to see a thriving, inclusive, and sustainable program.



Franchise law is a heavily regulated area of law.  We help clients expand their businesses through franchising and other distribution methods. We have experience in many industries including, restaurants, health, and beauty, alcohol, and cannabis among others. Our representative services include the following:


We also help potential franchisees interested in buying a franchise. We are able to assist with evaluation of franchise opportunities with respect to:

Alternative Structures

However, not all businesses are suited to franchise. We are also experienced with helping clients structure alternative distribution methods to prevent classification as a franchise.


Our M&A attorneys are highly experienced in counseling clients who are considering acquisitions or exit strategies.  We have many years of experience handling deals of various types and sizes, ranging from sales of small closely-held business, private companies, and publicly-traded corporations.  We have represented business owners, private equity firms and investment banks in a wide range of industries. 

We have a deep business bench, and Emerge attorneys have handled transactions of all shapes and sizes.  Whether your deal is valued at $100,000 or $100,000,000, our experienced attorneys will guide you through the deal process.

We understand the intensity, technical skill and judgment needed to get deals done, and we provide our clients with timely, practical and cost-effective legal advice.  We are highly capable in all aspects of M&A, including the following:


Emerge Law Group is highly experienced in the cannabis industry.  We have helped many clients obtain state licenses and local permits to operate cannabis businesses throughout California, Oregon, and Washington.

Emerge attorneys were instrumental in the drafting and passage of Oregon Measure 91, legalizing marijuana in the State of Oregon, and have represented cannabis businesses well before many law firms were willing to enter the cannabis industry. As a firm that has provided legal services in the cannabis space for many years, we are familiar with the unique and complex issues businesses and individuals face in an emerging and highly regulated industry.

We regularly help clients with:

Cannabis laws and rules are also regularly changing.  Members of our team are dedicated to attending legislative hearings, state agency and local city and county meetings to stay up-to-date on any new changes and how to adjust to any new changes.

See our Cannabis Industry page for more information.


There is tremendous excitement about the potential for psychedelic drugs to benefit a wide variety of populations, including terminally ill patients suffering with anxiety and depression. Until recently, psychedelic substances have been accessible only in the illicit market and are illegal under federal and state to manufacture, distribute, or possess. These substances have, since 1970, been treated as having no legitimate medical use, and no commercial application. As such, no one invested in this area or required legal services, outside of the criminal context.

Today, researchers in a multitude of clinical studies are proving the medical safety and efficacy of these medicines, with the objective of changing the treatment of these substances under the Controlled Substances Act. Companies are now actively raising money to develop intellectual property and seize market opportunities associated with psychedelic drugs.

In addition, advocates at the state and local levels are not waiting for the rescheduling of these substances and are active in undertaking efforts to decriminalize these substances and/or make them affirmatively legal under state and/or municipal law. Decriminalization already has occurred in cities including Denver, Oakland, Santa Cruz, and Ann Arbor. Oregon is poised to be the first state to make psilocybin therapy affirmatively legal. Emerge Law Group is working with a wide array of clients pushing forward in this emerging area.

See our Psychedelics Practice Group page for more information.



Businesses of all kinds benefit from a customized but systematic approach to structuring legal relationships. Emerge Law Group helps businesses and business owners with a variety of tax planning matters.

Representative client services include:


Estate planning encompasses everything from a will and power of attorney to combined estate and business succession planning. In almost all cases, the purpose of the plan is to help the client protect those they care about most in the event they can no longer be there for them.

Emerge Law Group has experience with a wide range of tools used in estate planning, including wills, trusts, and family business entity planning.


Emerge Law Group can assist with the resolution of difficult tax controversies. Our areas of emphasis and experience include:


Emerge Law Group assists clients with a wide range of real estate transactional matters.  We regularly help clients with:


Emerge Law Group also assists clients with all aspects of local government land use and development processes, ranging from preliminary property analyses and building permit issues to complex land use reviews and hearings. Our attorneys are experienced in obtaining land use entitlements and development permits for a wide range of uses.

We regularly help clients with:

Above all, we understand the value of working with cities and counties to enhance communities while developing the land to its potential. We strive to create solutions to land use issues that serve to better our clients and the communities in which they live and work.


The attorneys in Emerge Law Group’s Litigation and Alternative Dispute Resolution practice group litigate commercial, intellectual property, and public interest matters in state and federal courts, as well as private mediation and arbitration proceedings.  Our lawyers have represented national and regional financial institutions, major media, entertainment and technology companies, and other Fortune 500 companies in a broad array of high-stakes disputes.  Our team of litigators has handled leading cases that have shaped the law in cutting-edge business, technology, free speech, and public interest impact lawsuits in trial and the courts of appeal.

We have particular expertise in handling civil litigation and regulatory enforcement matters in the cannabis and psychedelic industries.  While many firms claim expertise in the these industries, few have our depth of experience successfully litigating contract, trademark, partnership, shareholder, land use, and real estate disputes in court and arbitration.  Even fewer firms have our level of experience handling writ of mandate proceedings against the government regulators.

Our litigators practice in California, Oregon, and Washington, but have appeared in state and federal courts nationwide.  Our knowledge of our clients’ businesses, goals and concerns, and our experience litigating at the highest levels, give us unique insight into possible outcomes and pitfalls as we continuously confront issues of new impression.

No matter what the industry, we pride ourselves in achieving our clients’ objectives through efficient and creative solutions primarily designed to avoid disputes in the first place—which is always the best litigation strategy.  Many times, our clients obtain excellent outcomes before or at the earliest stages of litigation because our adversaries quickly recognize the challenges they will face in litigating against us.  When litigation is unavoidable, however, we work hard to provide our clients with both cost-efficient and “big firm” quality representation.



Your intellectual property (or “IP”) strategy can harness your most valuable information and intangible assets including your name, your brand, your designs, your content, your services, and your products — what makes your business stand apart in a competitive world.  We can help you evaluate and build your IP portfolio, then secure it, monetize it, and protect it.

IP encompasses multiple areas of law and different types of information or material.

Our Intellectual Property practice focuses on:


Trademarks include names, signs, logos, designs, phrases, slogans, expressions, and sometimes even colors, sounds, or smells that identify or distinguish one business compared to others.  Trademark protection is fundamental in securing your “brand.”


Copyright covers original works of creative authorship fixed in a tangible medium of expression.  This includes literary, dramatic, musical, and artistic works, such as poetry, novels, designs, movies, songs, computer software, and architecture. Copyright does not protect facts, ideas, systems, or methods of operation, although it may protect the way these things are expressed.  Depending upon the type of work, “moral rights” (such as the right of attribution) may be implicated as well.


Trade secret laws can vary somewhat between states, but generally trade secrets cover information, including drawings, cost data, customer lists, formulas, recipes, patterns, compilations, programs, devices, methods, techniques or processes that derive economic value from not being generally known and are the subject of efforts that are “reasonable under the circumstances” to maintain secrecy.


Depending upon where you live or operate, there is a special patchwork of laws and regulations that protect and regulate personal information.  If you are handling or giving out personal or potentially sensitive information, you may be implicating privacy laws.


Publicity rights address the commercial use of an individual’s face, name, image, or likeness.  These rights vary state-to-state.  Marilyn Monroe, for example, lived in multiple states which created complex questions about her publicity rights.

Our Intellectual Property services include:


In states where new cannabis banking opportunities exist, Emerge Law Group has the proven expertise in creating canna-banking programs to efficiently capitalize on those opportunities. Our Banking Practice Group specializes in working with banks and credit unions to develop regulatory compliant programs and operational best practices. We also train banking staff to become experts in canna-banking so they can effective understand and manage the risk affiliated with canna-banking.

We regularly help clients with:


At Emerge Law Group, we recognize that employees are the heart and soul of any successful business.  Our Employment Law Practice Group works with employers to help them effectively manage their workforce, navigate the complex web of federal, state and local employment laws and, if necessary, defend against claims before administrative agencies and in court.

We regularly help clients with:


Our corporate finance and securities lawyers are experienced attorneys who have practiced at large law firms, worked as in-house counsel for public companies and investment banks, and owned and operated start-up companies. We work with clients to help achieve their financing goals while safely navigating the highly technical securities law landscape. 

In addition to representing issuers, we also routinely represent institutional and individual investors, including in connection with fund formation and investments.

Our expertise includes:

We have a deep understanding of the financing options available to businesses, including simple unsecured loans, asset-backed financing, convertible debt, common and preferred equity, crowdfunding and various other structures.  We work closely with our clients to understand their business and financing needs, ensure they are prepared to approach investors and choose the right partners, structure and negotiate terms, navigate the due diligence process and successfully close the deal.



Emerge attorneys have represented businesses in the alcohol and beverage industry, including wineries, breweries, distilleries, restaurants, bars, movie theaters, golf courses, and gas stations.  We can help you vet new locations, acquire existing locations, and apply for the appropriate liquor license.  We also provide training to comply with applicable rules and regulations, prepare operating procedures, submit renewals, and keep clients protected in the event of any potential violations or administrative hearings.


Emerge Law Group is highly experienced in the cannabis industry.  We have helped many clients obtain state licenses and local permits to operate cannabis businesses throughout California, Oregon, and Washington.  We regularly help clients with:

Cannabis laws and rules are also regularly changing.  Members of our team are dedicated to attending legislative hearings, state agency and local city and county meetings to stay up-to-date on any new changes and how to adjust to any new changes.

See our Cannabis Industry page for more information.


Emerge Law Group is a leader in the psychedelics industry.  There is tremendous excitement about the potential for psychedelic drugs to benefit a wide variety of populations, including veterans struggling with PTSD and terminally ill patients suffering with anxiety and depression.  Until recently, psychedelic substances have been accessible only in the underground; they are illegal under state and federal law to manufacture, distribute, or possess.  These substances have, since 1970, been treated as having no legitimate medical use, and no commercial application.  As such, businesses have not invested in this area or required legal services, outside of the criminal context.

Today, psychedelics are proceeding toward legalization on multiple paths.  Researchers in a multitude of clinical studies are proving the medical safety and efficacy of these medicines, with the objective of changing the treatment of these substances under the federal Controlled Substances Act, opening legal access to them.  Private and public companies are now actively raising money to develop intellectual property and capitalize on the market opportunities associated with psychedelic drugs.  Opportunities to be early actors in this new arena are tremendous.

See our Psychedelics Practice Group page for more information.


Our business transactions team is made up of highly experienced transactional attorneys who have practiced at large law and accounting firms, worked as in-house counsel for public companies and investment banks, and owned and operated start-up companies. We understand complex legal matters and provide high quality legal services in a cost-effective manner.  Our clients value our experience, knowledge and judgment.


Our team routinely advises clients regarding:


Emerge attorneys also advise on-going concerns with: